ARCHIVES

Letter to the Editors: Researchers Must Keep Up NIH Advocacy Particularly Now

This article is from The Cancer Letter archive.

Vol. 22 No. 39 | October 11, 1996

Download PDF Visit The Full Archive

Related Articles

New Phase III Trial Reviews Approve 25%; Should Trialists Worry? Not Yet,

January 19, 2007

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

FASEB Calls For 15% Increase For NIH Next Fiscal Year.

January 26, 2001

Skipper, Cohen, Burkitt Win GM $100,000 awards, Medal

June 18, 1982

DCPC Board Okays Reissuance Of RFA for Chemoprevention Clinical Trials

May 20, 1988

Court Filing By Fisher; Board, Attacks Interim NSABP Leadership

August 12, 1994